Aging is driven by a handful of biological processes that accumulate damage over decades, and the most effective strategies for slowing it target those processes directly. No single intervention reverses aging, but a growing body of evidence points to specific habits, compounds, and emerging therapies that measurably reduce the rate of cellular decline. Here’s what actually works, what’s promising, and what’s still unproven.
What Actually Drives Aging
Scientists have identified nine core hallmarks of aging that interact and reinforce each other. The most relevant ones for everyday decisions include genomic instability (accumulating DNA damage from sources like UV radiation, pollution, and normal metabolic byproducts), telomere shortening (the protective caps on your chromosomes getting shorter with each cell division), mitochondrial dysfunction (your cells’ energy generators becoming less efficient), and cellular senescence (damaged cells that stop dividing but refuse to die, leaking inflammatory signals into surrounding tissue).
Two other hallmarks matter for understanding why lifestyle changes help: deregulated nutrient sensing and loss of proteostasis. Your cells have built-in nutrient sensors that shift between growth mode and repair mode. When growth signaling stays chronically high, from constant eating or excess calories, cells spend less time on maintenance. Loss of proteostasis means your cells gradually lose the ability to fold proteins correctly and clear out damaged ones, which contributes to conditions like Alzheimer’s disease. Slowing aging, in practical terms, means intervening in as many of these processes as possible.
Caloric Restriction and Nutrient Sensing
Caloric restriction, reducing calorie intake by roughly 15 to 25 percent while maintaining full nutrition, is the most consistently replicated longevity intervention in animal research. It works at least partly by dialing down a protein complex called mTORC1, which acts as a master switch between cellular growth and cellular repair. When mTORC1 activity drops, cells shift toward autophagy, the recycling process that clears out damaged proteins and dysfunctional organelles. Research from the National Institute on Aging confirmed that reducing mTORC1 signaling alone extended lifespan in mice, independent of changes in blood sugar regulation.
You don’t necessarily need to count every calorie to get some of these benefits. Time-restricted eating (compressing your daily food intake into an 8- to 10-hour window) and periodic fasting both appear to activate similar nutrient-sensing pathways. The key principle is giving your body regular periods without incoming fuel, which triggers the shift from growth mode to maintenance mode. Chronic overnutrition does the opposite, keeping mTOR signaling high and suppressing the cellular cleanup processes that protect against age-related damage.
Exercise as an Anti-Aging Tool
Regular physical activity influences nearly every hallmark of aging simultaneously. It improves mitochondrial function by stimulating the creation of new mitochondria and clearing out damaged ones. It reduces the burden of senescent cells. It lowers chronic inflammation. And it activates AMPK, one of the same nutrient-sensing molecules triggered by caloric restriction, essentially mimicking some of the benefits of eating less.
The most robust evidence supports a combination of aerobic exercise and resistance training. Aerobic exercise (brisk walking, cycling, swimming) at moderate intensity for 150 minutes per week is associated with longer telomeres and improved cardiovascular markers. Resistance training preserves muscle mass and bone density, both of which decline sharply after age 50 and accelerate frailty. People who maintain both types of exercise into their 60s and 70s show biological age markers years younger than sedentary peers. The returns diminish at very high volumes, but the gap between doing nothing and doing moderate exercise is enormous.
Sleep and Brain Waste Clearance
During deep sleep, specifically the slow-wave stage known as N3, your brain activates a waste clearance system called the glymphatic system. Slow oscillatory brain waves create pulses of cerebrospinal fluid that flush through brain tissue in 20- to 30-second cycles, carrying away metabolic waste including amyloid-beta, the protein that accumulates in Alzheimer’s disease. The vast majority of this waste clearance happens during sleep, and it declines with age.
Poor sleep doesn’t just leave you tired. It allows neurotoxic proteins to accumulate, contributing to cognitive decline and raising dementia risk. Dementias are consistently associated with disrupted sleep, creating a vicious cycle where brain damage further impairs sleep quality. Prioritizing 7 to 8 hours of sleep, keeping a consistent schedule, and minimizing alcohol (which suppresses deep sleep even in small amounts) directly support this clearance system. Omega-3 fatty acid intake and regular exercise also appear to enhance glymphatic function.
NAD+ and NMN Supplements
NAD+ is a molecule your cells need for energy metabolism, DNA repair, and activating sirtuins, a family of proteins involved in cellular stress responses. NAD+ levels decline significantly with age, and restoring them has become one of the most popular targets in anti-aging research. NMN (nicotinamide mononucleotide) is a precursor that your body converts into NAD+.
Human clinical trials show that NMN supplementation produces a significant, dose-dependent increase in blood NAD+ levels. A blood NAD+ increase of about 15 nmol/L was associated with clinically meaningful improvements in physical function, measured by the 6-minute walk test, and in self-reported quality of life scores. However, the response varies dramatically between individuals. Within study groups, the variation in NAD+ increase ranged from 29 to 113 percent, meaning some people respond strongly and others barely at all. NMN is available as a supplement, but without testing your baseline NAD+ levels, you can’t easily predict how much benefit you’ll get. The science is real but still maturing.
Clearing Senescent Cells
Senescent cells are one of the most exciting targets in aging research. These are cells that have stopped dividing due to damage but resist the normal signals that would trigger their death. Instead, they linger in tissues and secrete a mix of inflammatory molecules that damage neighboring cells, a process sometimes called “zombie cell” accumulation. Over decades, the buildup of senescent cells contributes to tissue dysfunction, chronic inflammation, and age-related diseases.
A class of drugs called senolytics selectively kills these cells by temporarily disabling the survival pathways that protect them. The most studied combination pairs dasatinib (a cancer drug) with quercetin (a plant flavonoid). In a clinical trial of patients with diabetic kidney disease, a single 3-day course of this combination reduced senescent cell counts in both fat tissue and skin within 11 days, with no serious adverse events. An earlier trial in patients with a fatal lung disease called idiopathic pulmonary fibrosis showed statistically significant improvements in physical function after a brief course.
Senolytics are not yet approved for anti-aging use, and the trials so far have been small. But the principle, that periodically clearing damaged cells can improve tissue function, is one of the most promising directions in the field. Quercetin on its own is widely available as a supplement, though its senolytic effects at supplemental doses in otherwise healthy people remain unproven.
Protecting Your Skin From Aging
Skin aging is the most visible marker of the process, and one of the most modifiable. UV exposure drives the majority of visible skin aging (wrinkles, pigmentation, loss of firmness) through collagen breakdown. Daily broad-spectrum sunscreen is the single most effective anti-aging skincare step, and the evidence isn’t close.
For reversing existing damage, tretinoin (prescription-strength vitamin A) is the gold standard. A study published in the New England Journal of Medicine found that tretinoin applied to photodamaged skin produced an 80 percent increase in collagen formation, compared to a 14 percent decrease in the control group. That’s a striking effect for a topical treatment. Retinol, the over-the-counter form, works through the same mechanism but at lower potency. Consistent use over months thickens the dermal layer, reduces fine lines, and improves skin texture.
Measuring Your Biological Age
Chronological age tells you how many years you’ve been alive. Biological age tells you how much wear your cells have actually accumulated, and the two can diverge by a decade or more. Epigenetic clocks measure biological age by reading chemical tags on your DNA (methylation patterns) that shift predictably as cells age.
The most accurate current clocks, like DeepMAge, predict age with a median error of about 2.8 years. The widely used Horvath clock has an average error of 3.6 years, while the Hannum clock comes in at 3.9 years with a correlation of 0.96 between predicted and actual age. These tests are available through consumer testing services and can track whether your lifestyle changes are actually shifting your biological age over time. They’re not perfect, but they’re precise enough to be useful as a feedback tool.
Metformin and the Future of Anti-Aging Medicine
Metformin, a common diabetes medication, has been observed in large population studies to correlate with lower rates of cancer, heart disease, and dementia in people who take it. The TAME (Targeting Aging with Metformin) trial aims to test this formally: a six-year study across 14 research institutions, enrolling over 3,000 people aged 65 to 79, measuring whether metformin delays the onset or progression of multiple age-related diseases simultaneously. The study design is complete, but the trial is still seeking funding to launch.
What makes TAME significant isn’t just metformin itself. The trial’s larger goal is to establish “aging” as a condition the FDA recognizes as treatable. Currently, drugs can only be approved to treat specific diseases. If TAME succeeds, it would open the door for pharmaceutical companies to develop and test drugs that target aging as a whole, rather than treating heart disease, cancer, and dementia as entirely separate problems. That regulatory shift could reshape how medicine approaches age-related decline for decades to come.